Coronavirus News Essentials

Europe - Coronavirus

Coronavirus in Europe Essentials publishes only the best news and links related to the Covid-19 virus in Europe, carefully hand-picked and curated by top experts.

Top news of the week: 02.02.2021.

Vaccination
Infection
Vaccine
United Kingdom
Virus
Health care

Coronavirus

@nytimes shared
On Jan 27, 2021
The reuse of scarce protective equipment to fight Covid-19 has helped spread drug-resistant bacteria and fungi. These germs have taken advantage of the pandemic's chaos to grow in hospitals and nursing homes around the world. https://t.co/3Id7mxGrDq
Open
With All Eyes on Covid-19, Drug-Resistant Infections Crept In

With All Eyes on Covid-19, Drug-Resistant Infections Crept In

The spread of other dangerous germs is surging — a result, in part, of the chaotic response to the pandemic.

@nytimes shared
On Jan 30, 2021
RT @carlzimmer: While the push for a coronavirus vaccine has shattered records, the past year of searching for antivirals to block the coronavirus has been a disorganized disappointment. Here’s my look at what went wrong last year, and how things may go right this year. https://t.co/Np9sjR55rU
Open
How the Search for Covid-19 Treatments Faltered While Vaccines Sped Ahead

How the Search for Covid-19 Treatments Faltered While Vaccines Sped Ahead

Vaccine development exceeded everyone’s expectations. But the next few months will still bring many sick people — and doctors have woefully few drugs with which to treat them.

@WSJhealth shared
On Jan 28, 2021
RT @stefaniei: Viral vector. mRNA. The Covid-19 vaccines are different from one another. Here's a look at the four main technologies behind the shots that are on the market and in development. https://t.co/w2OpaSbfZP via @WSJGraphics
Open
Covid-19 Vaccines and How They Work

Covid-19 Vaccines and How They Work

There are more than a half dozen coronavirus vaccines in use or under development and they employ a variety of technologies.

@WSJhealth shared
On Jan 26, 2021
RT @stefaniei: “We have to still deal with ‘the right now.’” Scientists zero in on coronavirus protection protocols as potentially more-contagious variants emerge and vaccines get slow rollouts.  https://t.co/zHXTmVZg60 via @danielas_bot @sarahtoy17 @mccabe_caitlin
Open
New Playbook for Covid-19 Protection Emerges After Year of Study, Missteps

New Playbook for Covid-19 Protection Emerges After Year of Study, Missteps

Mask-wearing, good air flow and frequent rapid tests are more important than surface cleaning, temperature checks and plexiglass. Scientists say America needs to double down on protection ...

@GasteinForum shared
On Feb 1, 2021
RT @OBShealth: 🗓️Reminder about our weekly webinar series! This coming Tuesday 02 Feb at 12 pm we discuss the impact of #COVID19 lockdowns. Register here: https://t.co/83j1X9qTEp https://t.co/kokXVTtWjY
Open
12_WEBINAR_ COVID-19 lockdowns and their broader impact: social costs and potential co-benefits

12_WEBINAR_ COVID-19 lockdowns and their broader impact: social costs and potential co-benefits

KEYNOTE SPEAKER: Valentina Chiesa, Azienda Unità Sanitaria Locale – IRCCS di Reggio Emilia, Italy SPEAKERS: Liz Green, Public Health Wales, Wales (UK) Gabriele Antony, Austrian Public ...

@BBCBreaking shared
On Jan 28, 2021
Covid-19 vaccine Novavax - of which the British government has ordered 60 million doses - proves 89.3% effective in large-scale UK trials https://t.co/DOeyiI4GZk
Open
Covid-19: Novavax vaccine shows 89% efficacy in UK trials

Covid-19: Novavax vaccine shows 89% efficacy in UK trials

The Novavax jab is the first to show it is effective against the UK variant of the virus.

@bbchealth shared
On Feb 1, 2021
Covid-19: UK orders extra 40m doses of Valneva vaccine https://t.co/TI8wwezk5A
Open
Covid-19: UK orders extra 40m doses of Valneva vaccine

Covid-19: UK orders extra 40m doses of Valneva vaccine

Deliveries will come towards next winter when people may need to be revaccinated.

@WSJ shared
On Jan 29, 2021
The European Union's drug regulator recommended the use of AstraZeneca's coronavirus vaccine, saying the shot would likely work in people over 65 https://t.co/pXCSIuZmUH
Open
AstraZeneca’s Covid-19 Vaccine Wins EU Green Light Amid Controversy

AstraZeneca’s Covid-19 Vaccine Wins EU Green Light Amid Controversy

The European Union’s drug regulator recommended use of a Covid-19 vaccine from AstraZeneca PLC, but the approval is unlikely to quell growing political furor over its effectiveness, ...